Molecular imaging as a guide for the treatment of central nervous system disorders (original) (raw)
Related papers
PET and SPECT of Neurobiological Systems, 2020
Dopamine and psychiatric disorders: evidence from neuroimaging studies
Frontiers in Medicine
Positron emission tomography in CNS drug discovery and drug monitoring
Journal of medicinal chemistry, 2014
Molecular Imaging of Neuropsychiatry and Neuro-oncology
The Role of Imaging in Proof of Concept for CNS Drug Discovery and Development
Neuropsychopharmacology, 2009
Using positron emission tomography to facilitate CNS drug development
Trends in Pharmacological Sciences, 2006
Catecholamine Research in the 21ST Century
Pathway-specific dopamine abnormalities in schizophrenia
Biological Psychiatry, 2016
Imaging Approaches to Parkinson Disease
Journal of Nuclear Medicine, 2010
Advances in CNS Imaging Agents: Focus on PET and SPECT Tracers in Experimental and Clinical Use
CNS Drugs, 2015
Neurochemical Imaging in Schizophrenia
Current Topics in Behavioral Neurosciences, 2010
The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment
Archives of General Psychiatry, 2012
How have developments in molecular imaging techniques furthered schizophrenia research?
Imaging in Medicine, 2009
Molecular imaging (SPECT and PET) in the evaluation of patients with movement disorders
Nuclear Medicine Review Central Eastern Europe Journal of Bulgarian Czech Macedonian Polish Romanian Russian Slovak Yugoslav Societies of Nuclear Medicine and Ukrainian Society of Radiology, 2006
Psychological Medicine
Nuclear medicine review. Central & Eastern Europe: journal of Bulgarian, Czech, Macedonian, Polish, Romanian, Russian, Slovak, Yugoslav societies of nuclear medicine and Ukrainian Society of Radiology
Brain, 2013
Molecular Imaging of the Dopaminergic System and its Association with Human Cognitive Function
Masahiro Fujita, Pradeep Nathan
Biological Psychiatry, 2006
Presynaptic regulation of dopamine transmission in schizophrenia
Schizophrenia bulletin, 2011
Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers
Movement disorders : official journal of the Movement Disorder Society, 2017
Positron Emission Tomography in Schizophrenia: A New Perspective
In Vivo Imaging of Neurotransmission and Brain Receptors in Dementia
Journal of Neuroimaging, 2008
PET And SPECT Imaging in Psychiatric Disorders
SPECT neuroimaging in translational research of CNS disorders
Neurochemistry International, 2008
New tracers and new perspectives for molecular imaging in Lewy body diseases.
NeuroImage, 2010
Recent Developments in Neurochemical Imaging in Schizophrenia: An Update (2013)
Recent Developments in Neurochemical Imaging in Schizophrenia: An Update
B. Puri, Peter Herscovitch, Nora S Vyas
Current Medicinal Chemistry, 2013
Human evidence of a supra-spinal modulating role of dopamine on pain perception
Synapse, 2009
Challenges of Introducing New Biomarker Products for Neuropsychiatric Disorders into the Market
International Review of Neurobiology, 2011
Presynaptic Dopamine in Schizophrenia
CNS Neuroscience & Therapeutics, 2011
Neuroimaging diagnosis in neurodegenerative diseases
Elżbieta Mikiciuk-olasik, Agnieszka Janik
Nuclear medicine review. Central & Eastern Europe, 2010